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Abstract 
Trillium govanianum Wall. (Melanthiaceae alt. Trilliaceae), commonly known as ‘nag 
chhatri’ or ‘teen patra’, is a native species of the Himalayas. It is used in various 
traditional medicines containing both steroids and sex hormones. In folk medicine, the 
rhizomes of T.govanianum are used to treat boils, dysentery, inflammation, menstrual 
and sexual disorders, as an antiseptic and in wound healing. With the only exception of 
the recent report on the isolation of a new steroidal saponin, govanoside A, together with 
three known steroidal compounds with antifungal property from this plant, there has been 
no systematic pharmacological and phytochemical work performed on T. govanianum. 
This paper reports, for the first time, on the cytotoxicity of the methanol extract of the 
roots of T. govanianum and its solid-phase extraction (SPE) fractions against four human 
carcinoma cell lines: breast (MCF7), liver (HEPG2), lung (A549) and urinary bladder 
(EJ138), using the 3-(4,5-dimethylthiazol-2-yl)- 2,5-diphenyltetrazoliumbromide 
cytotoxicity assay and liquid chromatography and electrospray ionization quadrupole 
time-of-flight mass spectrometry analysis of the SPE fractions. The methanol extract and 
all SPE fractions exhibited considerable levels of cytotoxicity against all cell lines, with 
the IC50 values ranging between 5 and 16μg/mL. Like other Trillium species, presence of 
saponins and sapogenins in the SPE fractions was evident in the liquid chromatography 
mass spectrometry data.  
 
Introduction 
Trillium govanianum Wall. (Melanthiaceae alt. Trilliaceae), commonly known as ‘nag 
chhatri’ in India and ‘teen patra’ or ‘matar zela’ in Pakistan, is native to the Himalayas 
and also distributed from Pakistan to Bhutan between the altitudinal ranges of 2500–
3800m above the sea level (Uniyal and Datta, 2012; Shafiq- ur-Rahman et al., 2015). 
Since the report revealing the occurrence of the steroid, trillarin (Fig. 1), in this species 
(Chauhan, 1999), it has been extensively used in various traditional medicinal 
preparations that contain steroids and sex hormones, and now, it is one of the best-selling 
herbal products in the Indo-Pak subcontinent. However, only a few years ago, this plant 
was not even listed in the 960 traded medicinal plant species of India (Ved and Goraya, 
2007). The rhizomes of this plant have traditionally been used in folk medicine for the 
treatment of boils, dysentery, inflammation, menstrual and sexual disorders, as well as an 
antiseptic and in wound healing (Pant and Samant, 2010; Shafiq-ur-Rahman et al., 2015). 
Previous studies on some other species of the genus Trillium have established that this 
genus is rich in steroidal saponins (Fig. 1), for example, steroidal saponins were found in 
Trillium erectum L. (Yokosuka and Mimaki, 2008; Hayes et al., 2009), Trillium 
kamtschaticum Pall. (Ono et al., 1986, 2003, 2007; Yokosuka and Mimaki, 2008; Wei et 
al., 2012) and Trillium tschonoskii Maxim. (Nakano et al., 1983; Man et al., 2010; Wei et 
al., 2012; Wang et al., 2013). The dried roots of a few Trillium species that have been 
used traditionally for immunoregulation, as an antiinflammatory and anti-ageing agent, 
were found to possess antitumour properties (Luo et al., 2006; Wang et al., 2013). 
However, with the only exception of the recent report on the isolation and identification 
of a new steroidal saponin, govanoside A, together with three known steroidal 
compounds, barassoside E, diosgenin and pennogenin (Fig. 1), from this plant (Shafiq-ur-
Rahman et al., 2015) and showing their moderate level of antifungal property, to the best 
of our knowledge, there has been no systematic pharmacological and phytochemical 
work performed on T. govanianum. Therefore, the present study was undertaken to 
explore potential cytotoxicity of the methanol (MeOH) extract of he roots of T. 
govanianum and its solid-phase extraction (SPE) fractions against four human carcinoma 
cell lines: breast (MCF7), liver (HepG2), lung (A549) and urinary bladder (EJ138) using 
the in vitro 3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenyltetrazoliumbromide (MTT) 
cytotoxicity/ viability assay and to carry out preliminary liquid chromatography and 
electrospray ionization quadrupole time- of-flight (TOF) mass spectrometry analysis of 
the SPE fractions.  
Materials and methods 
Reagents and chemicals. Unless otherwise stated, all chemicals were purchased from 
Sigma-Aldrich (Dorset, UK). Solvents were purchased form Fischer Scientific 
(Loughborough, UK). All cell culture reagents were purchased from Biosera (Nauaille, 
France).  
Plant materials. Plant sample was collected from the Muzaffarabad district of Pakistan-
controlled Azad Kashmir and identified as T. govanianum Wall. by Dr Muhammad 
Zafar, Herbarium Botanist, Department of Plant Sciences, Quaid-I-Azam University, 
Islamabad, Pakistan. A herbarium specimen for this collection (voucher number: Acc no. 
128085) has been deposited and retained in the herbarium mentioned in the preceding 
texts.  
Extraction and preparation of plant samples. Shade dried and finely ground roots (2.5 
kg) of T. govanianum were macerated in MeOH (5 L) for 10 days at room temperature, 
filtered, and the solvent was evaporated under vacuum using a rotatory evaporator (<45 
°C) to obtain a concentrated gummy crude extract.  
Solid-phase extraction and sample purification. A portion of the dried MeOH extract (2 
g) was suspended in 20 mL of HPLC grade water and loaded on to a Strata C-18 
cartridge (20g), previously washed with MeOH (50 mL), followed by equilibration with 
water (100mL). The cartridge was eluted with MeOH–water mixture of decreasing 
polarity to obtain four fractions: 20, 50, 80 and 100% MeOH in water (250mL each), 
coded respectively as TGMF1, TGMF2, TGMF3 and TGMF4. All four fractions were 
evaporated to dryness using a combination of rotary evaporator and freeze- dryer, re-
dissolved in MeOH (10mg/mL), centrifuged at 12000r.p.m. for 3min, filtered through 
0.20μm of sterile syringe filter for injection (10 μL) into the liquid chromatography mass 
spectrometry (LC-MS) system.  
Liquid chromatography mass spectrometry. An Alliance HPLC System 2695 (Waters) 
was used. Reversed-phase chromatography was performed on a Phenomenex Gemini-NX 
5 μm C18 column (250 × 4.6 mm). The column temperature was set at 25°C. A variable 
wavelength ultraviolet–visible detector was set at 220 nm. An elution gradient was used 
with solvent A (0.1% formic acid in water) and solvent B (0.1% formic acid in MeOH). 
The initial mobile phase composition was 70% of A and 30% B at 0 min, then linear 
gradient to 100% of B over 30min and held at that composition for 5min at a flow rate of 
1 mL/min.  
The LC system was connected to a quadrupole TOF mass spectrometer (Waters 
Micromass LCT) equipped with an electrospray ion source. Response was recorded in 
real time by the mass spectrometer data system (Waters MassLynx version 4.1). The 
tuning parameters were set as follows: electrospray interface 3000 V, rangefinder lens 
250V, extraction cone set at 3V, desolvation temperature 20 °C, source temperature 100 
°C, nebulizer gas flow 20L/h desolvation gas flow 760L/handTOFtube4687V. Data 
acquisition method was set as follows: cycle time 1 s, scan duration 0.9 s, inter-scan 
delay 0.1 s, mass range 100 to 1600 and centroid mode. Positive ion mode was operated 
with cone voltage settings of 40 V. 
Cell lines, cell cultures and the MTT assay. The potential cytotoxicity of the MeOH 
extract of the roots of T. govanianum and its SPE fractions was studied against four 
human carcinoma cell lines: breast (MCF7), liver (HepG2), lung (A549) and urinary 
bladder (EJ138) using the MTT assay (Mosmann, 1983; Basar et al., 2015). The cells 
were washed by phosphate buffered sa- line and harvested by tripsinization. All cell lines 
were cultured in RPMI-1640 medium supplemented with 10% foetal bovine serum. The 
cells were cultured at 37 °C in 95% humidity and 5% CO2. For the MTT assay, the cells 
were seeded into 24 well plates at a density of 1.2 × 104 cells/well in a working volume 
of 1 mL/well and allowed to grow for 24 h before the commencement of each 
experiment.  
 
The cells were treated for 24 h with different concentrations of test samples (the MeOH 
extract and SPE fractions; 5, 10, 50, 100 and 500μg/mL). Dilution of stock solutions was 
made in culture medium yielding final sample concentrations with a final dimethyl 
sulfoxide concentration of 0.1%, including the control. Each sample was used to treat 
four wells of cells in each 24-well plate. After the 24-h treatment period, the toxicity of 
the samples on each carcinoma cell line was quantified. To achieve this, the medium in 
each well was replaced by MTT solution (500 μg/mL in medium) and incubated for 2h. 
Toxicity was assessed by the ability of the cells to reduce the yellow dye MTT to a blue 
formazan product (Popescu et al., 2015). The MTT reagent was removed, and the 
formazan crystals produced by viable cells were dissolved in isopropanol, and the OD560 
was determined with the microplate reader (CLARIO Star Microplate reader, BMG 
Labtech, UK). The average OD560 obtained from all the control wells (without test 
sample) on each plate was arbitrarily set at 100%, and the OD560 value for the average 
of wells of cells treated with each test samples was expressed as a percentage of this 
control. Each assay was performed on a minimum of three separate occasions, and the 
IC50 values for each sample on each cell line were calculated using Microsoft Excel 
version 2013.  
Statistical analysis. All experiments were carried out in triplicate on separate occasions. 
Data were expressed s means ± standard error of the mean. The graphs were plotted using 
nonlinear regression with the use of Microsoft Excel version 2013.  
Results and discussion  
The MeOH extract of the roots of T.govanianum (Table 1) and its SPE fractions 
(TGMF1, TGMF2, TGMF3 and TGMF4) exhibited different levels of significant 
cytotoxicity against four human carcinoma cell lines, for example, breast (MCF7), liver 
(HepG2), lung (A549) and urinary bladder (EJ138), using the in vitro MTT 
cytotoxicity/viability assay (Table 1). The IC50 values of the MeOH extract and its SPE 
fractions are shown in Table 1. The MeOH extract displayed the highest level of 
cytotoxicity against the urinary bladder cell line (EJ138; IC50 = 5 μg/mL), but it was also 
considerably active against three other cell lines, MCF7, HepG2 and A549 (IC50 = 5, 7 
and 9 μg/mL respectively). The SPE fraction TGMF1, which had the most polar 
components of the parent MeOH extract, showed most significant cytotoxicity against 
EJ138 (IC50 = 6 μg/mL) and considerable cytotoxicity against MCF7, HepG2 and A549, 
with the IC50 values of 9, 11 and 9μg/mL respectively. This SPE fraction was almost as 
potent as its parent MeOH extract in terms of cytotoxicity against the urinary bladder cell 
line EJ138. The SPE fraction TGMF2 showed most prominent cytotoxicity against the 
lung cancer cell line A549 (IC50 = 6 μg/mL) and was also active against other three cell 
lines, EJ138, MCF7 and HepG2 (IC50 = 11, 10 and 13 μg/mL respectively). The 
cytotoxicity pattern of the SPE fraction TGMF3 was quite similar to that of the TGMF1 
and the MeOH extract and showed most significant cytotoxicity against the EJ138 cell 
line (IC50 = 9 μg/mL). This fraction was also cytotoxic to the MCF7, A549 and HepG2 
cell lines with the IC50 values of 10, 13 and 16 μg/mL respectively. The SPE fraction 
TGMF4, which contained the least polar components of the parent MeOH extract, 
exhibited notable cytotoxicity against the EJ138 cell line (IC50 = 13 μg/mL) and was also 
considerably active against the HepG2, MCF7 and A549 cell lines (IC50 = 10, 13 and 15 
μg/mL respectively). With the only exception of TGMF2, three other SPE fractions 
showed the highest level of cytotoxicity against the EJ138 cell line, as was observed with 
their parent MeOH extract. To the best of our knowledge, this is the first report on the 
cytotoxicity of the MeOH extract of the roots of T.govanianum and its SPE fractions 
against any carcinoma cell lines. The current finding is concordant with the findings of a 
few other previous studies on the cytotoxicity of some other species of the genus Trillium 
(Nooter and Herweijer, 1991; Yokosuka and Mimaki, 2008; Hayes et al., 2009).  
The major bioactive components of the genus Trillium are saponins and sapogenins (Fig. 
1), which are well known to exhibit cytotoxicity (Nooter and Herweijer, 1991; Yokosuka 
and Mimaki, 2008; Hayes et al., 2009). Most of the compounds isolated from the genus 
Trillium described in the literature are saponins containing mono, di, tri or tetrasacchride 
(Fig. 1), commonly composed of apisoe, arabinose, glucose, rhamnose and xylose, which 
are linked to a β-D-glucosyl moiety at C3 of the aglycone (Gao et al., 2015). Paris 
saponin VII, a diosgenin-based saponin isolated from T. tschonoskii Maxim showed 
cytotoxicity against MCF7, human colorectal cancer cells-29 and SW-620 (IC50 = 9.547, 
IC50 = 1.02 ± 0.05 and 4.90 ± 0.23 μm respectively) (Li et al., 2014). Paris VII induced 
cell apoptosis together with caspase-3-dependent manner and cell cycle arrest in G1 
Phase. Two new saponins from the underground part of T.tschonoskii displayed strong 
cytotoxic activity against the HepG2 cell line (IC50 = 0.499 mmol/L) (Chai et al., 2014). 
A steroidal saponin from the same species exhibited prominent potential in combating 
multi-drug-resistance hepatocellular carcinoma (Wang et al., 2013). Six steroidal 
saponins isolated from the roots of T.erratum were shown to possess considerable 
cytotoxicity against the HL60 human promyelocytic leukaemia cells. From the same 
species, spirostanol and furostanol saponins showed moderate level of cytotoxicity (IC50 
= 1.68–8.85 μg/mL) (Yokosuka and Mimaki, 2008). Diosgenin, isolated as a major 
compound from Trillium species, showed potent cytotoxic effect against HepG2 and 
HCT116 cells in the MTT assay (Eskander et al., 2013). These are the type of compounds 
that could be also present in the roots of T. govanianum, and accordingly, preliminary 
LC-MS analysis was performed to test this hypothesis.  
Liquid chromatography mass spectrometry analysis on the SPE fractions of the MeOH 
extract of the roots of T.govanianum was performed to obtain an insight into the possible 
chemical composition of the fractions, particularly to have an indication whether they 
contain saponins and sapogenins as possible contributors to the significant cytotoxicity of 
the extract and its fractions. The chromatographic conditions were optimized by method 
development. A linear gradient elution with water and MeOH containing 0.1% formic 
acid as the mobile phase offered the best resolution. Typical chromatograms of fractions 
with mass spectrometric detection in positive ion mode exhibited quite complex patterns 
of peaks (Table 2), and only the possible presence of saponins (e.g. Paris saponin VII at 
tR 25.83, [M + 1] + m/z 1032) and sapogenins (e.g. diosgenin at tR 36.62, [M + 1] + m/z 
415) in SPE fractions could be suggested from the retention times and the MS spectral 
data of the separated peaks (Woldemichael and Wink, 2001; Madl et al., 2006; Hayes et 
al., 2009; Li et al., 2014; Gao et al., 2015; Shafiq-ur-Rahman et al., 2015). The presence 
of saponins and their aglycones in T.govanianum was in agreement with that of other 
Trillium species. It is reasonable to assume that the cytotoxicity of the MeOH extract and 
its SPE fractions of the roots of T. govanianum might be, at least partly, owing to the 
presence of saponins and their aglycones. This is also the first report on the preliminary 
LC-MS analysis on T. govanianum.  
Considering the significant cytotoxicity observed against four carcinoma cell lines in the 
current study and on the basis of the previously published data on the 
antitumour/anticancer potential of the genus Trillium as well as the presence of saponins 
in T.govanianum, it is reasonable to state that T. govanianum could be exploited as a 
good source of cytotoxic compounds with putative anticancer potential.  
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